IMS Health Holdings Given Consensus Rating of “Buy” by Brokerages (NYSE:IMS)
Shares of IMS Health Holdings (NYSE:IMS) have received a consensus rating of “Buy” from the fourteen analysts that are covering the stock, American Banking and Market News reports. Three analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $27.91.
Shares of IMS Health Holdings (NYSE:IMS) traded down 0.18% on Thursday, hitting $27.88. 40,872 shares of the company’s stock traded hands. IMS Health Holdings has a 52-week low of $21.63 and a 52-week high of $28.41. The stock’s 50-day moving average is $26.92 and its 200-day moving average is $25.17. The company’s market cap is $9.257 billion.
IMS Health Holdings (NYSE:IMS) last announced its earnings results on Thursday, July 24th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. The company had revenue of $662.00 million for the quarter, compared to the consensus estimate of $654.92 million. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts predict that IMS Health Holdings will post $1.38 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on IMS shares. Analysts at Goldman Sachs raised their price target on shares of IMS Health Holdings from $25.00 to $26.00 in a research note on Tuesday, August 5th. Separately, analysts at Drexel Hamilton initiated coverage on shares of IMS Health Holdings in a research note on Tuesday, August 5th. They set a “buy” rating and a $30.00 price target on the stock. Finally, analysts at Mizuho raised their price target on shares of IMS Health Holdings from $29.00 to $31.00 in a research note on Thursday, July 24th. They now have a “buy” rating on the stock.
IMS Health Holdings, Inc (NYSE:IMS) is a global information and technology services company providing solutions to the clients in the healthcare industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.